Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Poljak

Showing results (141-150 of 350) with videos related to

Pageof 35
Sort By:
Collegium Antropologicum|May 19, 2007
Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAARTSnjezana Zidovec Lepej, Ela Kosor, Alenka Gagro, et al.
Vaccine|December 4, 2012
Nucleic acid tests for the detection of alpha human papillomavirusesMario Poljak, Jack Cuzick, Boštjan J Kocjan, et al.
Hepato-Gastroenterology|March 13, 2003
Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?Bostjan Luzar, Vera Ferlan-Marolt, Vladimir Brinovec, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 2, 2011
Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequencesBoštjan J Kocjan, Mateja M Jelen, Polona J Maver, et al.
Viruses|October 27, 2022
An Improved Protocol for Comprehensive Etiological Characterization of Skin Warts and Determining Causative Human Papillomavirus Types in 128 Histologically Confirmed Common WartsLucijan Skubic, Lea Hošnjak, Vesna Breznik, et al.
Vaccines|October 28, 2025
Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination ProgramMateja Lasič, Anja Oštrbenk, Špela Smrkolj, et al.
Vaccine|September 3, 2013
Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening programVeronika Učakar, Mateja M Jelen, Helena Faust, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2015
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening settingMario Poljak, Anja Oštrbenk, Katja Seme, et al.
Journal of Cellular and Molecular Medicine|December 20, 2013
Verrucous carcinoma of the head and neck - not a human papillomavirus-related tumour?Katarina Odar, Boštjan J Kocjan, Lea Hošnjak, et al.
Journal of Medical Virology|December 25, 2008
Genomic diversity of human papillomavirus (HPV) genotype 38Bostjan J Kocjan, Katja Seme, Mojca Cimerman, et al.
Pageof 35

Showing results (141-150 of 350) with videos related to

Sort By:
Pageof 35
Collegium Antropologicum|May 19, 2007
Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAARTSnjezana Zidovec Lepej, Ela Kosor, Alenka Gagro, et al.
Vaccine|December 4, 2012
Nucleic acid tests for the detection of alpha human papillomavirusesMario Poljak, Jack Cuzick, Boštjan J Kocjan, et al.
Hepato-Gastroenterology|March 13, 2003
Does end-stage kidney failure influence hepatitis C progression in hemodialysis patients?Bostjan Luzar, Vera Ferlan-Marolt, Vladimir Brinovec, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 2, 2011
Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): a comparative analysis of 21 full-length genome sequencesBoštjan J Kocjan, Mateja M Jelen, Polona J Maver, et al.
Viruses|October 27, 2022
An Improved Protocol for Comprehensive Etiological Characterization of Skin Warts and Determining Causative Human Papillomavirus Types in 128 Histologically Confirmed Common WartsLucijan Skubic, Lea Hošnjak, Vesna Breznik, et al.
Vaccines|October 28, 2025
Prevalence of High-Risk Human Papillomaviruses (HPV) in Slovenian Women Attending Organized National Cervical Cancer Screening 14 Years After Implementation of the National HPV Vaccination ProgramMateja Lasič, Anja Oštrbenk, Špela Smrkolj, et al.
Vaccine|September 3, 2013
Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening programVeronika Učakar, Mateja M Jelen, Helena Faust, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 9, 2015
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening settingMario Poljak, Anja Oštrbenk, Katja Seme, et al.
Journal of Cellular and Molecular Medicine|December 20, 2013
Verrucous carcinoma of the head and neck - not a human papillomavirus-related tumour?Katarina Odar, Boštjan J Kocjan, Lea Hošnjak, et al.
Journal of Medical Virology|December 25, 2008
Genomic diversity of human papillomavirus (HPV) genotype 38Bostjan J Kocjan, Katja Seme, Mojca Cimerman, et al.
Pageof 35